Vaxart Stock Is Surging As Its Oral COVID-19 Vaccine Can Potentially Trigger Immunity Against VariantsBenzinga • 05/04/21
New Data from Vaxart Oral COVID-19 Vaccine Phase I Study Suggests Broad Cross-Reactivity against Other CoronavirusesGlobeNewsWire • 05/03/21
2 Biopharma Stocks Looking To Make A Difference Against COVID-19: Technical Levels To WatchBenzinga • 05/03/21
Vaxart Reports First Quarter 2021 Financial Results and Provides Business UpdateGlobeNewsWire • 05/03/21